Going through the threshold from 2017 to 2018, DBM endeavored to increase its engagement and by extension its visibility within the larger biotechnology community. Now entering Q4 of 2018, we…
DBM’s mission is to fill a critical niche within the modern drug discovery industry by specializing in custom human cell engineering and human cell-based drug discovery.
Our R&D infrastructure and know-how are leveraged as a CRO service to support the commercial and academic drug discovery community by integrating human cell research platforms at any and all points within the drug discovery critical path from HTS cell assay development and optimization to lead prioritization and progression, with the end product being ‘high value’ clinical candidates.
Going through the threshold from 2017 to 2018, DBM endeavored to increase its engagement and by extension its visibility within the larger biotechnology community. Now entering Q4 of 2018, we…
The period of 2017 and 2018 has realized a significant uptick in our CRO services business focused on diseased and normal human cell platform technology creation and in the use…
